Drug Trial Radar · NCT06787144
ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants
Last checked: Nov 20, 2026Latest source record: Jul 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
21
Planned (sponsor's estimate)
Start
Jan 23, 2025
Primary completion
Jan 2028
Study completion Jan 2028
Sponsor
- Lead sponsor
- Enliven TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jan 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability and determine the recommended dose for further clinical evaluation of ELVN-001 in Japanese patients with chronic phase chronic myeloid leukemia with and without T315I mutations in patients who has failed, or the patient is intolerant to, or not a candidate for, at least 2 prior TKIs.
Conditions
- CML (Chronic Myelogenous Leukemia)
- Chronic Phase CML
Interventions
ELVN-001Drug
Orally once or twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Incidence of dose limiting toxicitiesTime frame: 28 days
- Part 1: Incidence of adverse events (AEs)Time frame: Up to 28 days
- Part 1: Incidence of clinically significant laboratory abnormalitiesTime frame: Up to 28 days
- Part 1: Incidence of clinically significant ECG abnormalitiesTime frame: Up to 28 days
- Part 2: Incidence of adverse eventsTime frame: Up to 3 years
- Part 2: Incidence of clinically significant laboratory abnormalitiesTime frame: Up to 3 years
- Part 2: Incidence of clinically significant ECG abnormalitiesTime frame: Up to 3 years
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Akita University Hospital
Akita, Akita, Japan · Recruiting
Aiiku Hospital
Sapporo, Hokkaido, Japan · Recruiting
The University of Osaka Hospital
Suita-shi, Osaka, Japan · Recruiting
Tokyo Medical University Hospital
Shinjuku-ku, Tokyo, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.